ubenimex has been researched along with dinoprostone in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Göhring, B; Kehlen, A; Langner, J; Riemann, D | 1 |
Chen, X; Li, N; Newman, RA; Ramji, D; Sood, S; Sun, Z; Yang, CS; Yang, P | 1 |
de Castro Perez, A; de Francischi, JN; Gama Duarte, ID; Romero, TR | 1 |
Alves, DP; Caliari, MV; da Motta, PG; Duarte, ID; Francischi, JN; Lima, PP; Pacheco, CF; Pacheco, DF; Queiroz-Junior, CM | 1 |
Azevedo, AO; Caliari, MV; Duarte, ID; Guzzo, LS; Perez, AC; Queiroz-Junior, CM; Romero, TR | 1 |
Castor, MGME; Duarte, IDG; Guzzo, LS; Klein, A; Petrocchi, JA; Romero, TRL; Soares Santos, RR | 1 |
6 other study(ies) available for ubenimex and dinoprostone
Article | Year |
---|---|
Regulation of the expression of aminopeptidase A, aminopeptidase N/CD13 and dipeptidylpeptidase IV/CD26 in renal carcinoma cells and renal tubular epithelial cells by cytokines and cAMP-increasing mediators.
Topics: Adjuvants, Immunologic; Aminopeptidases; Calcimycin; Carcinoma, Renal Cell; CD13 Antigens; Cholera Toxin; Colforsin; Cyclic AMP; Cytokines; Dinoprostone; Dipeptidyl Peptidase 4; Epithelial Cells; Glutamyl Aminopeptidase; Humans; Ionophores; Kidney Neoplasms; Kidney Tubules; Leucine; Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 1998 |
Involvement of the 5-lipoxygenase/leukotriene A4 hydrolase pathway in 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch, and inhibition of carcinogenesis by its inhibitors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aniline Compounds; Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Arachidonate 5-Lipoxygenase; Carcinogens; Cheek; Cricetinae; Cysteine; Dinoprostone; Epoxide Hydrolases; Leucine; Mouth Neoplasms | 2006 |
Probable involvement of alpha(2C)-adrenoceptor subtype and endogenous opioid peptides in the peripheral antinociceptive effect induced by xylazine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Analgesics; Animals; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Idazoxan; Imidazoles; Leucine; Male; Naloxone; Opioid Peptides; Pain; Pain Measurement; Rats; Rats, Wistar; Xylazine; Yohimbine | 2009 |
Inflammation mobilizes local resources to control hyperalgesia: the role of endogenous opioid peptides.
Topics: Animals; beta-Endorphin; Carrageenan; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Inflammation; Leucine; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Pain Threshold; Protease Inhibitors; Rats; Rats, Wistar | 2012 |
Involvement of endogenous opioid peptides in the peripheral antinociceptive effect induced by the coffee specific diterpene kahweol.
Topics: Analgesics; Animals; beta-Endorphin; Coffee; Dinoprostone; Diterpenes; Hyperalgesia; Leucine; Male; Naloxone; Narcotic Antagonists; Opioid Peptides; Pain; Pain Measurement; Peptides; Pressure; Rats; Rats, Wistar; Skin | 2015 |
Noradrenaline induces peripheral antinociception by endogenous opioid release.
Topics: Analgesics; Animals; Cinnamates; Dinoprostone; Dose-Response Relationship, Drug; Hyperalgesia; Leucine; Male; Morphine Derivatives; Naltrexone; Norepinephrine; Opioid Peptides; Pain Measurement; Prazosin; Propranolol; Rats; Yohimbine | 2018 |